Hospice Announces March 2026 Revenue of NT$317 Million (Year-over-Year Increase of +5.1%)
NQ Score
1/100
N1 Content Completeness
0.7
AI Summary (NQ-processed)
Hospice (Stock Code: 1734), a company in the biotechnology and healthcare sector, reported its March 2026 revenue at NT$317.169 million, marking a 5.1% increase compared to the same period last year. This growth underscores the company's expanding presence and performance within the dynamic biotech and medical industry.
AI Analysis
Frequently Asked Questions
- Q: What was Hospice's revenue for March 2026?
- A: Hospice's revenue for March 2026 was 317,169,000 yuan (317 million yuan).
- Q: What was the year-over-year percentage change in revenue?
- A: Revenue increased by 5.1% compared to the same month last year.
- Q: Which industry does Hospice belong to?
- A: Hospice belongs to the biotechnology and healthcare industry.